These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 12141281)

  • 21. What happens to children growing up with HIV infection? It's time for a HAART to heart.
    Viganò A; Pattarino G; Cerini C; Zuccotti GV
    Expert Rev Anti Infect Ther; 2009 Jun; 7(5):495-8. PubMed ID: 19485788
    [No Abstract]   [Full Text] [Related]  

  • 22. Side effects and complications. French study clears HAART of cancer link in kids.
    TreatmentUpdate; 2009 Feb; 21(2):7-8. PubMed ID: 19391264
    [No Abstract]   [Full Text] [Related]  

  • 23. Side effects and complications. HAART and the safety of the fetus.
    TreatmentUpdate; 2009 Feb; 21(2):6-7. PubMed ID: 19391263
    [No Abstract]   [Full Text] [Related]  

  • 24. Current perspectives on the management and prevention of antiretroviral-associated lipoatrophy.
    Phillips DR; Hay P
    J Antimicrob Chemother; 2008 Nov; 62(5):866-71. PubMed ID: 18703527
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of highly active antiretroviral therapy on the incidence and clinical manifestations of visceral leishmaniasis in human immunodeficiency virus-infected patients.
    Fernández Cotarelo MJ; Abellán Martínez J; Guerra Vales JM; Martínez Sánchez P; Rodrigo Gómez De La Bárcena M; Salto Fernández E
    Clin Infect Dis; 2003 Oct; 37(7):973-7. PubMed ID: 13130410
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Highly active antiretroviral therapy (HAART) in HIV-positive pregnant women in the Netherlands, 1997-2003: safe, effective and with few side effects].
    Tempelman C; Timmermans S; Godfried MH; Dieleman JP; Boer K; van der Ende ME
    Ned Tijdschr Geneeskd; 2004 Oct; 148(41):2021-5. PubMed ID: 15553999
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-nucleoside-reverse-transcriptase-inhibitor-based HAART and osteoporosis in HIV-infected subjects.
    Bongiovanni M; Fausto A; Cicconi P; Aliprandi A; Cornalba G; Bini T; Sardanelli F; D'Arminio Monforte A
    J Antimicrob Chemother; 2006 Aug; 58(2):485-6. PubMed ID: 16751202
    [No Abstract]   [Full Text] [Related]  

  • 28. Hypercalcaemia complicating immune reconstitution in an HIV-infected patient with disseminated tuberculosis.
    Ferrand RA; Elgalib A; Newsholme W; Childerhouse A; Edwards SG; Miller RF
    Int J STD AIDS; 2006 May; 17(5):349-50. PubMed ID: 16643687
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Complications and side effects. Is it age or AIDS?
    TreatmentUpdate; 2005; 17(4):4-5. PubMed ID: 17228468
    [No Abstract]   [Full Text] [Related]  

  • 30. Anti-HIV agents. Should HAART begin right after an HIV diagnosis?
    TreatmentUpdate; 2009; 21(3):2-3. PubMed ID: 19630120
    [No Abstract]   [Full Text] [Related]  

  • 31. Peyronie's disease in men with HIV responding to highly active antiretroviral therapy.
    Rogers GD; French MA
    HIV Med; 2004 May; 5(3):185-6. PubMed ID: 15139986
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Salivary gland function in HIV-infected patients treated with highly active antiretroviral therapy (HAART).
    Lin AL; Johnson DA; Sims CA; Stephan KT; Yeh CK
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Sep; 102(3):318-24. PubMed ID: 16920540
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transient haemolytic anaemia due to ecstasy in a patient on HAART.
    Goorney BP; Scholes P
    Int J STD AIDS; 2002 Sep; 13(9):651. PubMed ID: 12243137
    [No Abstract]   [Full Text] [Related]  

  • 34. Cardiovascular disease and toxicities related to HIV infection and its therapies.
    Zareba KM; Miller TL; Lipshultz SE
    Expert Opin Drug Saf; 2005 Nov; 4(6):1017-25. PubMed ID: 16255661
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prolongation and quality of life for HIV-infected adults treated with highly active antiretroviral therapy (HAART): a balancing act.
    Burgoyne RW; Tan DH
    J Antimicrob Chemother; 2008 Mar; 61(3):469-73. PubMed ID: 18174196
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complications and side effects. Falling rates of heart attacks.
    TreatmentUpdate; 2009; 21(3):8-9. PubMed ID: 19623729
    [No Abstract]   [Full Text] [Related]  

  • 37. Highly active antiretroviral therapy (HAART) among HIV-infected drug users: a prospective cohort study of sexual risk and injecting behaviour.
    Smit C; Lindenburg K; Geskus RB; Brinkman K; Coutinho RA; Prins M
    Addiction; 2006 Mar; 101(3):433-40. PubMed ID: 16499516
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Beyond lipodystrophy: will toxicity issues ever outweigh the benefits of HAART?
    Vella S; Palmisano L
    J HIV Ther; 2003 May; 8(2):27-8. PubMed ID: 15587479
    [No Abstract]   [Full Text] [Related]  

  • 39. Antiretroviral therapy in HIV-infected children: the metabolic cost of improved survival.
    Leonard EG; McComsey GA
    Infect Dis Clin North Am; 2005 Sep; 19(3):713-29. PubMed ID: 16102657
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pathologic fracture of the sacrum in an HIV patient treated with highly active antiretroviral therapy].
    Nuevo JA; Moreno F; González-Castillo J; Téllez MJ; Roca V; Vergas J
    An Med Interna; 2003 Sep; 20(9):496-7. PubMed ID: 14755911
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.